Skip to main content
86801 Suchergebnisse für:

Hepatitis A 

sortieren nach |
"Aktualität" sortiert die Ergebnisse nach Publikationsdatum. "Relevanz" berücksichtigt auch noch andere Faktoren wie zum Beispiel die Häufigkeit der Suchbegriffe im Text.
  1. 08.03.2024 | Online First

    A comparative study of uncomplicated acute non-A-E hepatitis with acute viral hepatitis and acute onset autoimmune hepatitis

    Non-A-E hepatitis (NAEH) is a well-recognized cause for acute liver failure (ALF). It is also known as indeterminate, cryptogenic, seronegative, non-A non-B, non-A non-B non-C and non-A non-E hepatitis [ 1 ]. It is a common indication for liver …

  2. Open Access 01.12.2024 | OriginalPaper

    Characteristics and clinical treatment outcomes of chronic hepatitis B children with coexistence of hepatitis B surface antigen (HBsAg) and antibodies to HBsAg

    Despite the implementation of universal vaccination programs, hepatitis B virus (HBV) infection of children remains a significant global public health challenge [ 1 – 3 ]. According to the report from WHO in 2015, the prevalence of hepatitis B

  3. 19.03.2024 | Online First

    Granulomatous hepatitis with Crohn’s disease: a case report

    A 45-year-old man who was regularly followed up for Crohn’s disease (CD) and maintained clinical remission with vedolizumab (VDZ). At 37 years old, he was diagnosed CD from longitudinal ulcers in the distal ileum by balloon-assisted enteroscopy …

  4. 07.03.2024 | Online First

    Viral hepatitis–induced acute liver failure

    Viral hepatitis–induced acute liver failure (ALF) is a preventable cause for liver-related mortality worldwide. Viruses are the most common cause for ALF in developing nations in contrast to the west, where acetaminophen is largely responsible.

  5. 18.03.2024 | Online First

    Hepatocellular Carcinoma in the Era of Direct Antiviral Agents Against Hepatitis C Virus

    The hepatitis C virus (HCV), a single-stranded RNA virus belonging to the Flaviviridae family, is globally responsible for more than 150,000 deaths from hepatocellular carcinoma (HCC), every year [ 1 ]. This is the inevitable consequence of 58.5 …

  6. 13.12.2023 | Toxische Hepatitis | Nachrichten | Online-Artikel
    Hohe Triglyzeridwerte als Marker

    Foamy-Degeneration statt Alkohol-Hepatitis?

    Ein kleiner Teil der Patienten mit Verdacht auf eine alkoholassoziierte Hepatitis hat offenbar eine weit weniger gefährliche Foamy-Degeneration. Solche Personen lassen sich vor allem über stark erhöhte Triglyzeridwerte erkennen.

  7. Open Access 01.12.2024 | OriginalPaper

    Unraveling IL-17 and IL-22 role in occult hepatitis C versus chronic hepatitis C virus infection

    Around the world, chronic hepatitis C virus infection (CHC) is a primary health concern affecting the liver [ 1 , 2 ]. Recently, a different type of CHC infection has been discovered, referred to as occult hepatitis C infection (OHCV) [ 3 ].

  8. Open Access 01.12.2024 | OriginalPaper

    Patients’ experience of accessing hepatitis C treatment through the Myanmar national hepatitis C treatment program: a qualitative evaluation

    Globally, approximately 56.8 million people are living with hepatitis C and over three-quarters of those reside in low and middle-income countries (LMICs) [ 1 ]. Since the introduction of direct-acting antiviral (DAA) treatments for hepatitis C

  9. Open Access 01.02.2024 | ReviewPaper

    Advances and Challenges in Managing Hepatitis D Virus: Evolving Strategies

    Hepatitis D Virus (HDV), also known as hepatitis delta virus, is the smallest yet one of the most potent pathogens, presenting a formidable global public health threat. HDV infection occurs in individuals who are co-infected with hepatitis B virus …

  10. Open Access 01.12.2024 | OriginalPaper

    Viscoelastic parameters derived from multifrequency MR elastography for depicting hepatic fibrosis and inflammation in chronic viral hepatitis

    Chronic liver diseases caused by viral hepatitis infections represent a significant global health concern [ 1 , 2 ]. Fibrosis, a well-documented consequence of these diseases, is a dynamic process that can be reversed with appropriate treatment …

  11. Open Access 01.12.2024 | OriginalPaper

    Patients with chronic hepatitis B who have persistently normal alanine aminotransferase or aged < 30 years may exhibit significant histologic damage

    Chronic hepatitis B virus (HBV) infection, which can lead to cirrhosis and hepatocellular carcinoma (HCC), remains a major public health concern [ 1 ]. Elimination of hepatogenic HBV or clearance of hepatitis B surface antigen (HBsAg), stalling …

  12. 10.02.2024 | OriginalPaper

    Effectiveness and Safety of Tenofovir Alafenamide Fumarate in the Prevention of Perinatal Hepatitis B Transmission: A Meta-Analysis

    Chronic hepatitis B (CHB), which is associated with a high risk of cirrhosis and cancer, is a life-threatening liver disease that affects 257 million people worldwide [ 1 ]. Mother-to-child transmission (MTCT), which accounts for the majority of …

  13. 12.03.2024 | Online First

    Availability, price, and affordability of anti-hepatitis B virus drugs: a cross-sectional study in China

    The overall availability of anti-HBV drugs in Jiangsu, China, was low, indicating that even with lower prices, the access of residents to drugs was restricted due to insufficient supply. Drug prices in Jiangsu, China, were favorable compared to the …

  14. 29.01.2024 | Online First

    Assessing Physicians’ Recommendations for Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Testing Among Minority Populations in Greater Philadelphia and New York City

    Deaths from liver cancer are on the rise and disproportionately affect minority racial/ethnic groups. In this study, we examined associations between physicians’ recommendations for hepatitis B virus (HBV) and hepatitis C virus (HCV) screening and …

  15. Open Access 01.12.2024 | Erratum

    Correction: Impact of preoperative antiviral therapy on the prognosis of hepatitis B virus-related hepatocellular carcinoma

  16. Open Access 01.12.2024 | OriginalPaper

    Hepatitis B vaccine effectiveness among vaccinated children in Africa: a systematic review and meta-analysis

    Hepatitis B virus (HBV) infection is a serious health problem causing a substantial burden of acute and chronic liver disease [ 1 , 2 ]. Today, more than 257 million people worldwide are chronically infected with HBV. Despite an effective vaccine …

  17. Open Access 01.12.2024 | OriginalPaper

    Collateral effects of COVID-19 countermeasures on hepatitis E incidence pattern: a case study of china based on time series models

    Hepatitis E is a major public health problem and one of the most frequent causes of acute hepatitis worldwide. The global burden of hepatitis E is high; every year, there are approximately 20 million hepatitis E virus (HEV) infections, leading to …

  18. Open Access 01.12.2024 | OriginalPaper

    Hypermethylation of the glutathione peroxidase 4 gene promoter is associated with the occurrence of immune tolerance phase in chronic hepatitis B

    Viral hepatitis B is a viral infection that damages the liver and can cause acute or chronic disease. Chronic infection with HBV can progress to liver cirrhosis and hepatocellular carcinoma(HCC), which is a serious threat to human health and …

  19. Open Access 01.12.2024 | OriginalPaper

    Prevalence and factors associated with hepatitis b vaccination uptake and completion among communities targeted for mass vaccination in gulu: a cross-sectional study

    The global prevalence of hepatitis B remains high at 3.9% with many people undiagnosed or not enrolled in treatment [ 1 ]. The prevalence and mortality registered in sub-Saharan Africa are even higher although the vaccine existed since 1982 [ 2 ].

  20. 15.02.2024 | OriginalPaper

    Outcome of Infants Born to Women with Chronic Hepatitis B: A Local Risk-Based Strategy in a Low Prevalence Country

    Chronic hepatitis B virus (HBV) infection due to mother-to-child transmission (MTCT) during the perinatal period remains an important global health problem (WHO, 2020a , 2017 ). In high-prevalence areas, such as Asia, Africa, and some …

Suchergebnisse filtern:

e.Medpedia

Hepatitis A

DGIM Innere Medizin
Bei der Hepatitis A handelt es sich um eine infektiöse Entzündung der Leber. Hepatitis A kommt hauptsächlich in tropischen Entwicklungsländern mit reduziertem Hygienestandard vor. Der Verlauf einer HAV-Infektion variiert stark und reicht von asymptomatischen Kontakten mit dem Virus bis hin zu cholestatischer Hepatitis A oder gar akutem Leberversagen. Initial treten häufig unspezifische Symptome wie Schwäche, Übelkeit, Brechreiz oder Fieber auf, erst im weiteren Verlauf kommt es zu Ikterus, Pruritus, dunkel-verfärbtem Urin und entfärbtem Stuhl. Etwa 10 % der Krankheitsfälle nehmen einen biphasischen Verlauf. Zur Diagnosestellung stehen Seroassays zur Testung auf HAV-spezifische Antikörper und PCR-Assays zur Testung auf HAV-RNA zur Verfügung. Es gibt zwar eine Impfung, aber keine etablierte Therapie gegen die Hepatitis A.

weitere e.Medpedia Einträge

Suchoperatoren:

„ ... ... “ Findet Dokumente mit genau dieser Wortgruppe in exakt dieser Schreibweise und Reihenfolge (z.B., "rheumatische Beschwerden").
AND / UND Findet Dokumente, in denen beide Begriffe zusammen vorkommen (z.B., alkohol UND demenz).
OR / ODER Findet Dokumente, in denen einer der beiden oder beide Begriffe vorkommen (z.B., hiv ODER aids).
Leerzeichen Findet Dokumente, in denen alle Begriffe vorkommen. Der Leerschritt wird als UND interpretiert (z.B., isolierte systolische hypertonie).
NOT / NICHT Findet Dokumente, in denen der Begriff nach NOT nicht vorkommt (z.B., sars NOT sars-cov-2).
COUNT(...)>n Findet Dokumente, in denen der gesuchte Begriff mehr als n mal vorkommt. n steht für eine beliebige Anzahl (z.B., COUNT(mammakarzinom)>8).
NEAR(..., ..., ) Findet Dokumente, in denen beide Begriffe in beliebiger Reihenfolge innerhalb von maximal n Worten zueinander stehen. Empfehlung: wählen Sie zwischen 15 und 30 als maximale Wortanzahl (z.B., NEAR(covid, diabetes,20)).
* Findet Dokumente, in denen der Begriff in Wortvarianten vorkommt, wobei diese VOR, HINTER oder VOR und HINTER dem Suchbegriff anschließen können (z.B., thrombose*, *thrombose, *thrombose*).
? Findet Dokumente mit dem Suchbegriff in verschiedenen Schreibweisen, hier mit s oder z, also organisation und organization. Das ? steht für eine einzige Stelle (z.B., organi?ation).
& + - Sonderzeichen werden als UND interpretiert (z.B., Diagnose + Therapie).

Sie können Operatoren mit Ihrer Suchanfrage kombinieren, um diese noch präziser einzugrenzen.

Fahren Sie mit der Maus über den Suchoperator, um eine Erklärung seiner Funktionsweise anzuzeigen.